| scholarly article | Q13442814 |
| P2093 | author name string | Torsten Pietsch | |
| Christine Haberler | |||
| P2860 | cites work | Molecular subgroups of medulloblastoma: the current consensus | Q24615271 |
| Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition | Q27852966 | ||
| beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee | Q28279527 | ||
| Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort | Q33764662 | ||
| Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement | Q36048155 | ||
| Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups | Q36460209 | ||
| Medulloblastoma comprises four distinct molecular variants | Q36920479 | ||
| Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma | Q36929844 | ||
| Molecular subgroups of adult medulloblastoma: a long-term single-institution study | Q36977713 | ||
| Active medulloblastoma enhancers reveal subgroup-specific cellular origins | Q37517791 | ||
| Molecular stratification of medulloblastoma: comparison of histological and genetic methods to detect Wnt activated tumours | Q39181104 | ||
| Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas | Q40156627 | ||
| OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas | Q40319823 | ||
| Integrating Molecular Subclassification of Medulloblastomas into Routine Clinical Practice: A Simplified Approach | Q40682183 | ||
| Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors | Q40795419 | ||
| Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations | Q43826621 | ||
| Nodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behavior | Q48227672 | ||
| Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas. | Q51542148 | ||
| Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients. | Q53286039 | ||
| p75(NTR) induces apoptosis in medulloblastoma cells. | Q54424271 | ||
| Adult medulloblastoma comprises three major molecular variants. | Q55463035 | ||
| P433 | issue | 6 | |
| P921 | main subject | medulloblastoma | Q1333608 |
| diagnosis | Q16644043 | ||
| P304 | page(s) | 344-352 | |
| P577 | publication date | 2016-10-26 | |
| P1433 | published in | Clinical Neuropathology | Q15763518 |
| P1476 | title | Update on the integrated histopathological and genetic classification of medulloblastoma - a practical diagnostic guideline | |
| P478 | volume | 35 |
| Q55409347 | Concurrent IDH1 and SMARCB1 Mutations in Pediatric Medulloblastoma: A Case Report. |
| Q89460155 | Developmental Maturation of the Cerebellar White Matter-an Instructive Environment for Cerebellar Inhibitory Interneurons |
| Q36193595 | Distinction of Neurons, Glia and Endothelial Cells in the Cerebral Cortex: An Algorithm Based on Cytological Features |
| Q91665138 | EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma |
| Q38629781 | Imaging Biomarkers for Adult Medulloblastomas: Genetic Entities May Be Identified by Their MR Imaging Radiophenotype. |
| Q51731284 | Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation. |
| Q91711195 | Methylation Profiling of Medulloblastoma in a Clinical Setting Permits Sub-classification and Reveals New Outcome Predictions |
| Q38841348 | OTX2 expression contributes to proliferation and progression in Myc-amplified medulloblastoma |
| Q55176029 | Recent Advancement of the Molecular Diagnosis in Pediatric Brain Tumor. |
| Q48302746 | TP53 Mutation, MYCN Amplification, and Large Cell/Anaplastic Histology in Medulloblastoma |
Search more.